It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Improvement to the life expectancy of people with cystic fibrosis (PWCF) brings about novel
challenges including the need for evaluation of the role of fungi in the cystic fibrosis (CF) …

Chronic pulmonary aspergillosis (CPA) is a group of consuming diseases usually presenting
with prolonged and relapsing cough, dyspnoea and weight loss. Acute symptoms such as …

Chronic lung infections with opportunistic bacterial and fungal pathogens are a major cause
of morbidity and mortality especially in patients with cystic fibrosis. Pseudomonas …

Background Pathogen surveillance is challenging but crucial in children with cystic fibrosis—
who are often non-productive of sputum even if actively coughing—because infection and …

Aspergillus fumigatus frequently colonizes the airways of patients with cystic fibrosis (CF)
and may cause various severe infections, such as bronchitis. Serological data, sputum …

Galactosaminogalactan and Pel are cationic heteropolysaccharides produced by the
opportunistic pathogens Aspergillus fumigatus and Pseudomonas aeruginosa, respectively …

With intensified antibiotic therapy and longer survival, patients with cystic fibrosis (CF) are
colonized with a more complex pattern of bacteria and fungi. However, the clinical relevance …

Respiratory infection in cystic fibrosis (CF) is polymicrobial, but standard sputum
microbiology does not account for the lung microbiome or detect changes in microbial …

While the true value of phage therapy (PT) in human bacterial infections still awaits formal
confirmation by clinical trials, new data have been accumulating indicating that in the future …